Procter & Gamble (NYSE:PG) Given New $183.00 Price Target at Evercore ISI

Procter & Gamble (NYSE:PG) had its target price increased by Evercore ISI from $177.00 to $183.00 in a report published on Thursday morning, Benzinga reports. Evercore ISI currently has an outperform rating on the stock.

A number of other research firms have also commented on PG. Citigroup lifted their price objective on Procter & Gamble from $177.00 to $190.00 and gave the stock a buy rating in a research note on Wednesday, July 10th. Deutsche Bank Aktiengesellschaft boosted their price target on Procter & Gamble from $171.00 to $176.00 and gave the company a buy rating in a research note on Wednesday. StockNews.com lowered Procter & Gamble from a buy rating to a hold rating in a research note on Tuesday. Barclays boosted their price target on Procter & Gamble from $168.00 to $170.00 and gave the company an overweight rating in a research note on Tuesday, April 23rd. Finally, Argus boosted their price target on Procter & Gamble from $180.00 to $185.00 and gave the company a buy rating in a research note on Thursday, April 25th. Seven equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, Procter & Gamble presently has an average rating of Moderate Buy and a consensus target price of $172.55.

Procter & Gamble Stock Performance

Shares of PG stock opened at $168.43 on Thursday. The business’s 50-day moving average price is $166.28 and its 200-day moving average price is $160.68. Procter & Gamble has a 12 month low of $141.45 and a 12 month high of $170.92. The firm has a market capitalization of $397.52 billion, a price-to-earnings ratio of 27.52, a PEG ratio of 3.25 and a beta of 0.41. The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Friday, April 19th. The company reported $1.52 EPS for the quarter, topping analysts’ consensus estimates of $1.42 by $0.10. The company had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.43 billion. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The firm’s quarterly revenue was up .6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.37 earnings per share. Equities research analysts forecast that Procter & Gamble will post 6.55 EPS for the current year.

Procter & Gamble Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be given a $1.0065 dividend. The ex-dividend date of this dividend is Friday, July 19th. This represents a $4.03 annualized dividend and a yield of 2.39%. Procter & Gamble’s dividend payout ratio is currently 65.85%.

Insiders Place Their Bets

In other Procter & Gamble news, insider Balaji Purushothaman sold 28,369 shares of the business’s stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total value of $4,581,309.81. Following the transaction, the insider now owns 11,507 shares of the company’s stock, valued at $1,858,265.43. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Procter & Gamble news, insider Balaji Purushothaman sold 28,369 shares of the business’s stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total value of $4,581,309.81. Following the transaction, the insider now owns 11,507 shares of the company’s stock, valued at $1,858,265.43. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO R. Alexandra Keith sold 855 shares of the company’s stock in a transaction on Monday, April 22nd. The shares were sold at an average price of $158.50, for a total value of $135,517.50. Following the transaction, the chief executive officer now directly owns 4,004 shares in the company, valued at approximately $634,634. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 154,544 shares of company stock valued at $25,413,051. Insiders own 0.17% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Advantage Trust Co purchased a new position in shares of Procter & Gamble during the 4th quarter valued at $28,000. Naples Money Management LLC purchased a new stake in Procter & Gamble during the 4th quarter worth about $29,000. Transcendent Capital Group LLC purchased a new stake in Procter & Gamble during the 4th quarter worth about $31,000. Ruedi Wealth Management Inc. lifted its holdings in Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after purchasing an additional 77 shares in the last quarter. Finally, Criterion Capital Advisors LLC purchased a new stake in Procter & Gamble during the 4th quarter worth about $33,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.